Skip to main content

Advertisement

Table 6 Gene sets enriched in lymph node negative patients

From: The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures

LN- Gene Set Name Inferred Biological Activity Genes Represented ES
Long Term Remission SHEN_SMARCA2_TARGETS_UP Epigenetic 347 0.65
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP   321 0.60
BOQUEST_STEM_CELL_UP Stemness 239 0.57
ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE EMT 60 0.71
SMID_BREAST_CANCER_LUMINAL_A_UP   78 0.67
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP Immune 171 0.58
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN   52 0.71
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN Radiation 409 0.52
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP Immune 480 0.51
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN PAX3-FOXO1 down 386 0.52
Distant Metastasis SHEN_SMARCA2_TARGETS_DN Epigenetic 312 −0.54
RICKMAN_HEAD_AND_NECK_CANCER_F   47 −0.72
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP   130 −0.54
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER Proliferation 124 −0.51
KEGG_OLFACTORY_TRANSDUCTION Signalling 66 −0.58
REACTOME_STRIATED_MUSCLE_CONTRACTION   27 −0.70
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP IGF 58 −0.58
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN AKT/HGF 81 −0.51
MIKKELSEN_MEF_ICP_WITH_H3K27ME3 Epigenetic 118 −0.48
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 Epigenetic 15 −0.76